Krystal Biotech, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US5011471027
USD
254.95
4.87 (1.95%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
389.13
290.51
50.70
0.00
0.00
0.00
0.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
389.13
290.51
50.70
0.00
0.00
0.00
0.00
Raw Material Cost
28.77
26.81
8.10
4.05
2.77
1.85
0.97
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
146.74
106.94
93.39
76.28
39.42
13.21
5.49
Other Expenses
5.23
5.36
4.64
3.99
2.61
1.79
1.56
Total Expenditure (Excl Depreciation)
227.84
187.32
147.93
120.20
68.28
33.00
22.08
Operating Profit (PBDIT) excl Other Income
161.29999999999998
103.2
-97.2
-120.19999999999999
-68.3
-33
-22.1
Other Income
28.18
29.66
122.62
5.22
-1.29
0.83
2.99
Operating Profit (PBDIT)
196.02
139.60
30.40
-110.92
-66.80
-30.32
-18.11
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
0.00
-37.50
-12.50
-25.00
0.00
0.00
0.00
Gross Profit (PBDT)
360.36
263.71
42.60
-4.05
-2.77
-1.85
-0.97
Depreciation
6.55
6.75
5.01
4.05
2.77
1.85
0.97
Profit Before Tax
189.47
95.36
12.90
-139.97
-69.57
-32.17
-19.09
Tax
-15.36
6.20
1.97
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
204.83
89.16
10.93
-139.97
-69.57
-32.17
-19.09
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
204.83
89.16
10.93
-139.97
-69.57
-32.17
-19.09
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
204.83
89.16
10.93
-139.97
-69.57
-32.17
-19.09
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,219.56
946.38
778.64
522.23
593.58
292.08
202.91
Earnings per share (EPS)
6.84
3.0
0.39
-5.49
-3.13
-1.71
-1.2
Diluted Earnings per share
6.84
3.0
0.39
-5.49
-3.13
-1.71
-1.2
Operating Profit Margin (Excl OI)
41.45%
35.52%
-191.77%
0.0%
0.0%
0.0%
0.0%
Gross Profit Margin
50.37%
35.15%
35.31%
0.0%
0.0%
0.0%
0.0%
PAT Margin
52.64%
30.69%
21.56%
0.0%
0.0%
0.0%
0.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 33.94% vs 472.98% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 129.60% vs 718.35% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 52.68% vs 219.20% in Dec 2024

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Krystal Biotech, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
389.13
638.50
-249.37
-39.06%
Other Operating Income
0.00
0.00
0.00
Total Operating income
389.13
638.50
-249.37
-39.06%
Raw Material Cost
28.77
56.54
-27.77
-49.12%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
15.93
-15.93
-100.00%
Selling and Distribution Expenses
146.74
568.41
-421.67
-74.18%
Other Expenses
5.23
16.68
-11.45
-68.65%
Total Expenditure (Excl Depreciation)
227.84
807.73
-579.89
-71.79%
Operating Profit (PBDIT) excl Other Income
161.29
-169.24
330.53
195.30%
Other Income
28.18
9.37
18.81
200.75%
Operating Profit (PBDIT)
196.02
-150.80
346.82
229.99%
Interest
0.00
15.93
-15.93
-100.00%
Exceptional Items
0.00
-7.91
7.91
100.00%
Gross Profit (PBDT)
360.36
581.95
-221.59
-38.08%
Depreciation
6.55
9.06
-2.51
-27.70%
Profit Before Tax
189.47
-183.70
373.17
203.14%
Tax
-15.36
-0.53
-14.83
-2,798.11%
Provisions and contingencies
0
0
0.00
Profit After Tax
204.83
-183.17
388.00
211.83%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
204.83
-183.17
388.00
211.83%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
204.83
-183.17
388.00
211.83%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,219.56
88.30
1,131.26
1,281.16%
Earnings per share (EPS)
6.84
-3.68
10.52
285.87%
Diluted Earnings per share
6.84
-3.68
10.52
285.87%
Operating Profit Margin (Excl OI)
41.45%
-26.51%
0.00
67.96%
Gross Profit Margin
50.37%
-27.35%
0.00
77.72%
PAT Margin
52.64%
-28.69%
0.00
81.33%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 38.91 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 33.94% vs 472.98% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 20.48 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 129.60% vs 718.35% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 16.78 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 52.68% vs 219.20% in Dec 2024

Annual - Interest
Markets Mojo
No Interest in the last few periods
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 41.45%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024